Monoclonal antibody benralizumab was found to be more effective than the standard treatment in a clinical trial.

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...

The APG777 + APG990 coformulation has been shown to retain stability, injectability, and convenience of individual components. In preclinical studies it has demonstrated broad inhibition of Type 1, ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

CORBIN — Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that makes breathing increasingly difficult. Common symptoms include chronic coughing, wheezing, phlegm production, ...

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.

Researchers at King's College London have found a new treatment for asthma attacks, which could be a 'game-changer' for the patients.

To join the webcast, please vsit this link or the News & Events page of the Investors section on the Company’s website https://apogeetherapeutics.com. A replay of the webcast will be archived and ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

A study reveals Benralizumab as a new treatment for asthma and COPD, reducing treatment failure rates significantly.

For the first time in 50 years, a new treatment has been found to improve care for people experiencing asthma or COPD ...

Researchers say they have found the first new treatment for asthma attacks in 50 years. The injection dampens part of the ...